Literature DB >> 29679492

Knowledge-based automated planning for oropharyngeal cancer.

Aaron Babier1, Justin J Boutilier1, Andrea L McNiven2,3, Timothy C Y Chan1,4.   

Abstract

PURPOSE: The purpose of this study was to automatically generate radiation therapy plans for oropharynx patients by combining knowledge-based planning (KBP) predictions with an inverse optimization (IO) pipeline.
METHODS: We developed two KBP approaches, the bagging query (BQ) method and the generalized principal component analysis-based (gPCA) method, to predict achievable dose-volume histograms (DVHs). These approaches generalize existing methods by predicting physically feasible organ-at-risk (OAR) and target DVHs in sites with multiple targets. Using leave-one-out cross validation, we applied both models to a large dataset of 217 oropharynx patients. The predicted DVHs were input into an IO pipeline that generated treatment plans (BQ and gPCA plans) via an intermediate step that estimated objective function weights for an inverse planning model. The KBP predictions were compared to the clinical DVHs for benchmarking. To assess the complete pipeline, we compared the BQ and gPCA plans to both the predictions and clinical plans. To isolate the effect of the KBP predictions, we put clinical DVHs through the IO pipeline to produce clinical inverse optimized (CIO) plans. This approach also allowed us to estimate the complexity of the clinical plans. The BQ and gPCA plans were benchmarked against the CIO plans using DVH differences and clinical planning criteria. Iso-complexity plans (relative to CIO) were also generated and evaluated.
RESULTS: The BQ method tended to predict that less dose is delivered than what was observed in the clinical plans while the gPCA predictions were more similar to clinical DVHs. Both populations of KBP predictions were reproduced with inverse plans to within a median DVH difference of 3 Gy. Clinical planning criteria for OARs were satisfied most frequently by the BQ plans (74.4%), by 6.3% points more than the clinical plans. Meanwhile, target criteria were satisfied most frequently by the gPCA plans (90.2%), and by 21.2% points more than clinical plans. However, once the complexity of the plans was constrained to that of the CIO plans, the performance of the BQ plans degraded significantly. In contrast, the gPCA plans still satisfied more clinical criteria than both the clinical and CIO plans, with the most notable improvement being in target criteria.
CONCLUSION: Our automated pipeline can successfully use DVH predictions to generate high-quality plans without human intervention. Between the two KBP methods, gPCA plans tend to achieve comparable performance as clinical plans, even when controlling for plan complexity, whereas BQ plans tended to underperform.
© 2018 American Association of Physicists in Medicine.

Entities:  

Keywords:  IMRT; inverse optimization; knowledge-based planning; machine learning; treatment planning

Mesh:

Year:  2018        PMID: 29679492     DOI: 10.1002/mp.12930

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  18 in total

1.  Intelligent inverse treatment planning via deep reinforcement learning, a proof-of-principle study in high dose-rate brachytherapy for cervical cancer.

Authors:  Chenyang Shen; Yesenia Gonzalez; Peter Klages; Nan Qin; Hyunuk Jung; Liyuan Chen; Dan Nguyen; Steve B Jiang; Xun Jia
Journal:  Phys Med Biol       Date:  2019-05-29       Impact factor: 3.609

2.  Automatic configuration of the reference point method for fully automated multi-objective treatment planning applied to oropharyngeal cancer.

Authors:  Rens van Haveren; Ben J M Heijmen; Sebastiaan Breedveld
Journal:  Med Phys       Date:  2020-03-05       Impact factor: 4.071

3.  Using deep learning to predict beam-tunable Pareto optimal dose distribution for intensity-modulated radiation therapy.

Authors:  Gyanendra Bohara; Azar Sadeghnejad Barkousaraie; Steve Jiang; Dan Nguyen
Journal:  Med Phys       Date:  2020-08-02       Impact factor: 4.071

4.  Assessing the robustness of artificial intelligence powered planning tools in radiotherapy clinical settings-a phantom simulation approach.

Authors:  Martin Hito; Wentao Wang; Hunter Stephens; Yibo Xie; Ruilin Li; Fang-Fang Yin; Yaorong Ge; Q Jackie Wu; Qiuwen Wu; Yang Sheng
Journal:  Quant Imaging Med Surg       Date:  2021-12

5.  Artificial Intelligence in Radiation Therapy.

Authors:  Yabo Fu; Hao Zhang; Eric D Morris; Carri K Glide-Hurst; Suraj Pai; Alberto Traverso; Leonard Wee; Ibrahim Hadzic; Per-Ivar Lønne; Chenyang Shen; Tian Liu; Xiaofeng Yang
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2021-08-24

6.  A comparison of Monte Carlo dropout and bootstrap aggregation on the performance and uncertainty estimation in radiation therapy dose prediction with deep learning neural networks.

Authors:  Dan Nguyen; Azar Sadeghnejad Barkousaraie; Gyanendra Bohara; Anjali Balagopal; Rafe McBeth; Mu-Han Lin; Steve Jiang
Journal:  Phys Med Biol       Date:  2021-02-24       Impact factor: 3.609

7.  A population health perspective on artificial intelligence.

Authors:  Maxime Lavigne; Fatima Mussa; Maria I Creatore; Steven J Hoffman; David L Buckeridge
Journal:  Healthc Manage Forum       Date:  2019-05-19

8.  A Model-Based Method for Assessment of Salivary Gland and Planning Target Volume Dosimetry in Volumetric-Modulated Arc Therapy Planning on Head-and-Neck Cancer.

Authors:  Honglai Zhang; Yijian Cao; Jeffrey Antone; Adam C Riegel; Maged Ghaly; Louis Potters; Abolghassem Jamshidi
Journal:  J Med Phys       Date:  2019 Jul-Sep

9.  Machine Learning Techniques Applied to Dose Prediction in Computed Tomography Tests.

Authors:  Antonio-Javier Garcia-Sanchez; Enrique Garcia Angosto; Jose Luis Llor; Alfredo Serna Berna; David Ramos
Journal:  Sensors (Basel)       Date:  2019-11-22       Impact factor: 3.576

10.  Guest Editorial: RTT Workshops-Preparing the RTT profession for the future.

Authors:  Mary Coffey; Michelle Leech; Harald Hentschel; Ingrid Kristensen; Annette Boejen; Philipp Scherer
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.